<sup>18</sup>F-FDG PET/CT在食管癌中的临床应用

李菲; 黄俊星; 张俊; 李菲; 黄俊星; 张俊

doi:10.3760/cma.j.issn.1673-4114.2016.04.009

[1]

Parkin DM, Bray F, Ferlay J, et al.Global cancer statistics, 2002[J].CA Cancer J Clin, 2005, 55(2): 74-108.DOI: 10.3322/canjclin.55.2.74.

[2]

Lee MS, Mamon HJ, Hong TS, et al.Preoperative cetuximab, irinotecan, cisplatin, and radiation therapy for patients with locally advanced esophageal cancer[J].Oncologist, 2013, 18(3): 281-287.DOI: 10.1634/theoncologist.2012-0208.

[3]

Lee DH, Kim HR, Kim DK, et al.Outcomes of cervical lymph node recurrence in patients with esophageal squamous cell carcinoma after esophagectomy with 2-field lymph node dissection[J].J Thorac Cardiovasc Surg, 2013, 146(2): 365-371.DOI: 10.1016/j.jtcvs.2013.01.043.

[4]

陈俊强, 李建成, 朱坤寿, 等.食管癌转移淋巴结大小和肿瘤浸润深度对¹⁸F-FDG SPET/CT诊断准确性的影响[J].肿瘤基础与临床, 2011, 24(1): 54-57.DOI: 10.3969/j.issn.1673-5412.2011.01.024.
Chen JQ, Li JC, Zhu KS, et al.The influnce of Esophageal cancer metastasis lymph node size, and tumor infiltration depth on diagnostic accuracy of ¹⁸F-FDG SPET/CT[J].J Basic Clin Oncol, 2011, 24(1): 54-57. doi: 10.3969/j.issn.1673-5412.2011.01.024

[5]

Pfau PR, Perlman SB, Stanko P, et al.The role and clinical value of EUS in a multimodality esophageal carcinoma staging program with CT and positron emission tomography[J].Gastrointest Endosc, 2007, 65(3): 377-384.DOI: 10.1016/j.gie.2006.12.015.

[6]

Shimpi RA, George J, Jowell P, et al.Staging of esophageal cancer by EUS: staging accuracy revisited[J].Gastrointest Endosc, 2007, 66(3): 475-482.DOI: 10.1016/j.gie.2007.03.1051.

[7]

Heeren PA, Van Westreenen HL, Geersing GJ, et al.Influence of tumor characteristics on the accuracy of endoscopic ultrasonography in staging cancer of the esophagus and esophagogastric junction[J].Endoscopy, 2004, 36(11): 966-971.DOI: 10.1055/s-2004-825956.

[8]

Rollins KE, Lucas E, Tewari N, et al.PET-CT offers accurate assessment of tumour length in oesophageal malignancy[J].Eur J Radiol, 2015, 84(2): 195-200.DOI: 10.1016/j.ejrad.2014.10.014.

[9]

Cuellar SL, Carter BW, Macapinlac HA, et al.Clinical staging of patients with early esophageal adenocarcinoma: does FDG-PET/CT have a role?[J].J Thorac Oncol, 2014, 9(8): 1202-1206.DOI: 10.1097/JTO.0000000000000222.

[10]

Manabe O, Hattori N, Hirata K, et al.Diagnostic accuracy of lymph node metastasis depends on metabolic activity of the primary lesion in thoracic squamous esophageal cancer[J].J Nucl Med, 2013, 54(5): 670-676.DOI: 10.2967/jnumed.112.110304.

[11]

Yu W, Fu XL, Zhang YJ, et al.A prospective evaluation of staging and target volume definition of lymph nodes by ¹⁸FDG PET/CT in patients with squamous cell carcinoma of thoracic esophagus.[J/OL].Int J Radiat Oncol Biol Phys, 2011, 81(5): e759-765[2016-02-14].http://www.ncbi.nlm.nih.gov/pubmed/21470788.DOI: 10.1016/j.ijrobp.2010.10.065.

[12]

李军凯, 左效艳, 许文, 等.PET/CT对于食管癌放射治疗的研究进展[J].中国医药导刊, 2012, 14(8): 1311-1313.DOI: 10.3969/j.issn.1009-0959.2012.08.013.
Li JK, Zuo XY, Xu W, et al.The research progress of PET/CT for esophageal cancer radiotherapy[J].Chin J Med Guide, 2012, 14(8): 1311-1313. doi: 10.3969/j.issn.1009-0959.2012.08.013

[13]

叶雪梅, 张春燕, 章晨, 等. ¹⁸F-FDG SPECT/CT显像在食管癌治疗前分期诊断中的应用价值[J].肿瘤学杂志, 2012, 18(10): 762-767. doi: 10.3760/cma.j.issn.1673-422X.2012.10.013
Ye XM, Zhang CY, Zhang C, et al.The application value of ¹⁸F-FDG SPECT/CT imaging in the diagnosis of esophageal cancer treatment before staging[J].J Oncol, 2012, 18(10): 762-767. doi: 10.3760/cma.j.issn.1673-422X.2012.10.013

[14]

Shi WD, Wang WC, Wang J, et al.Meta-analysis of (18)FDG PET-CT for nodal staging in patients with esophageal cancer[J].Surg Oncol, 2013, 22(2): 112-116.DOI: 10.1016/j.suronc.2013.02.003.

[15]

Domínguez LM, Rayo JI, Serrano J, et al.Uncommon isolated distant subcutaneous tissue and skeletal muscle metastasis from oesophageal cancer diagnosed by ¹⁸F-FDG PET/CT[J].Rev Esp Med Nucl Imagen Mol, 2016, 35(1): 38-41.DOI: 10.1016/j.remn.2015.07.005.

[16]

Malik V, Johnston C, Donohoe C, et al.¹⁸F-FDG PET-detected synchronous primary neoplasms in the staging of esophageal cancer: incidence, cost, and impact on management[J].Clin Nucl Med, 2012, 37(12): 1152-1158.DOI: 10.1097/RLU.0b013e31827083ba.

[17]

Shum WY, Hsieh TC, Yeh JJ, et al.Clinical usefulness of dual-time FDG PET-CT in assessment of esophageal squamous cell carcinoma[J].Eur J Radiol, 2012, 81(5): 1024-1028.DOI: 10.1016/j.ejrad.2011.03.018.

[18]

Chen SH, Chan SC, Chao YK, et al.Detection of synchronous cancers by fluorodeoxyglucose positron emission tomography/computed tomography during primary staging workup for esophageal squamous cell carcinoma in Taiwan[J/OL].PLoS One, 2013, 8(11): e82812[2016-02-14].http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0082812.DOI: 10.1371/journal.pone.0082812.

[19]

Miyazaki T, Sohda M, Higuchi T, et al.Effectiveness of FDG-PET in screening of synchronous cancer of other organs in patients with esophageal cancer[J].Anticancer Res, 2014, 34(1): 283-287.

[20]

王胜军, 杨卫东, 赵小虎, 等.¹⁸F-FDG PET/CT诊断多发癌的价值[J].国际放射医学核医学杂志, 2013, 37(2): 96-99.DOI: 10.3760/cma.j.issn.1673-4114.2013.02.009.
Wang SJ, Yang WD, Zhao XH, et al.Value of ¹⁸F-FDG PET/CT in the diagnosis of multiple primary malignant neoplasms[J].Int J Radiat Med Nucl Med, 2013, 37(2): 96-99. doi: 10.3760/cma.j.issn.1673-4114.2013.02.009

[21]

任宝志, 钟立松, 袁建军.¹⁸FDG PET/CT定位三维适形放疗食管癌的疗效和预后分析[J].中国肿瘤临床与康复, 2010, 17(4): 338-341.DOI: 10.1021/la101229p.
Ren BZ, Zhong LS, Yuan JJ, et al.Analysis of the curative effect and prognosis of esophageal cancer in three-dimensional conformal radiotherapy positioning of ¹⁸FDG PET/CT[J].Chin J Clin Oncol Rehabil, 2010, 17(4): 338-341. doi: 10.1021/la101229p

[22]

Seol KH, Lee JE.PET/CT planning during chemoradiotherapy for esophageal cancer[J].Radiat Oncol J, 2014, 32(1): 31-42.DOI: 10.3857/roj.2014.32.1.31.

[23]

Muijs CT, Beukema JC, Woutersen DA, et al.Clinical validation of FDG-PET/CT in the radiation treatment planning for patients with oesophageal cancer[J].Radiather Oncol, 2014, 113(2): 188-192.DOI: 10.1016/j.radonc.2014.10.016.

[24]

Pan L, Gu P, Huang G, et al.Prognostic significance of SUV on PET/CT in patients with esophageal cancer: a systematic review and meta-analysis[J].Eur J Gastroenterol Hepatol, 2009, 21(9): 1008-1015.DOI: 10.1097/MEG.0b013e328323d6fa.

[25]

Elimova E, Wang X, Etchebehere E, et al.18-fluorodeoxy-glucose positron emission computed tomography as predictive of response after chemoradiation in oesophageal cancer patients[J].Eur J Cancer, 2015, 51(17): 2545-2552.DOI: 10.1016/j.ejca.2015.07.044.

[26]

Metser U, Rashidi F, Moshonov H, et al.¹⁸F-FDG-PET/CT in assessing response to neoadjuvant chemoradiotherapy for potentially resectable locally advanced esophageal cancer[J].Ann Nucl Med, 2014, 28(4): 295-303.DOI: 10.1007/s12149-014-0812-2.

[27]

Huang JW, Yeh HL, Hsu CP, et al.To evaluate the treatment response of locally advanced esophageal cancer after preoperative chemoradiotherapy by FDG-PET/CT scan[J].J Chin Med Assoc, 2015, 78(4): 229-234.DOI: 10.1016/j.jcma.2014.11.003.